Literature DB >> 3287447

Therapy of disseminated tumors by adoptive transfer of specifically immune T cells.

P D Greenberg, J P Klarnet, D E Kern, M A Cheever.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3287447     DOI： 10.1159/000414675

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  8 in total

Review 1.  IL-2 and Beyond in Cancer Immunotherapy.

Authors:  John M Wrangle; Alicia Patterson; C Bryce Johnson; Daniel J Neitzke; Shikhar Mehrotra; Chadrick E Denlinger; Chrystal M Paulos; Zihai Li; David J Cole; Mark P Rubinstein
Journal:  J Interferon Cytokine Res       Date:  2018-02       Impact factor: 2.607

2.  Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumours.

Authors:  M Rodolfo; C Bassi; C Salvi; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.

Authors:  Y S Kim; R Slomski; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.

Authors:  Xiao-Lin Li; Dongqing Zhang; David Knight; Yoshinobu Odaka; Jonathan Glass; J Michael Mathis; Qian-Jin Zhang
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

5.  Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells.

Authors:  C Bryce Johnson; Bennett R May; Brian P Riesenberg; Samantha Suriano; Shikhar Mehrotra; Elizabeth Garrett-Mayer; Mohamed L Salem; Emily K Jeng; Hing C Wong; Chrystal M Paulos; John M Wrangle; David J Cole; Mark P Rubinstein
Journal:  Cancer Res       Date:  2018-04-10       Impact factor: 12.701

Review 6.  Biomarkers in T cell therapy clinical trials.

Authors:  Michael Kalos
Journal:  J Transl Med       Date:  2011-08-19       Impact factor: 5.531

7.  Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.

Authors:  Sophie Paczesny; Jacques Banchereau; Knut M Wittkowski; Giovanna Saracino; Joseph Fay; A Karolina Palucka
Journal:  J Exp Med       Date:  2004-06-01       Impact factor: 14.307

8.  Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.

Authors:  J F Lacerda; M Ladanyi; D C Louie; J M Fernandez; E B Papadopoulos; R J O'Reilly
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.